Passive enhanced safety surveillance for Vaxigrip and Intanza 15 µg in the United Kingdom and Finland during the northern hemisphere influenza season 2015/16

por Bricout, Hélène, Chabanon, Anne Laure, Souverain, Audrey, Sadorge, Christine, Vesikari, Timo, Caroe, Timothy David
Publicado 2017

Immunogenicity and safety results from a randomized multicenter trial comparing a Tdap-IPV vaccine (REPEVAX(®)) and a tetanus monovalent vaccine in healthy adults: New consideratio...

por Laurichesse, Henri, Zimmermann, Ulrich, Galtier, Florence, Launay, Odile, Duval, Xavier, Richard, Patrick, Sadorge, Christine, Soubeyrand, Benoit
Publicado 2012